IP Library › Granted Patent US 9,320,465
Granted Patent B2
US 9,320,465 · App. 13/532,375 · Granted Apr 26, 2016

Bio-chips and nano-biochips

Inventor: Eric V. Kline (Rochester, MN)
Assignee: International Business Machines Corporation
A61B5/1473A61B5/07A61B5/14503A61B5/14507A61B8/085A61B8/12A61B2562/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,320,465
App. No.
13/532,375
Granted
Apr 26, 2016
Kind
B2
Abstract

A biochip and nanochip device, or a system of biochips, providing diagnostic testing, sensing and therapeutic functionality useful in diagnosis and treatment of a variety of physiological maladies.

Claims (12)

1. A biocompatible nanochip for treatment of a medical condition in a subject, the nanochip having a length, width and height dimension of less than 5 μm and comprising:

a semiconductor substrate upon which is located:

one or more sensor devices for sensing conditions and providing measurements within said subject,

a programmed control unit and an associated memory block configured for controlling operations on said nanochip in response to received external command or a sensed condition within said subject; and,

a communications sub-system including one or more communications devices for transmitting signals to and receiving signals from a communications receiver device external to said subject;

a power source for powering said communications sub-system and said programmed control unit; and, an external biocompatible coating or covering for said semiconductor substrate.

2. The nanochip of claim 1 , wherein the nanochip is implanted into a fixed position within the subject.

3. The nanochip of claim 1 , wherein the microchip is mobile within the subject.

4. The nanochip of claim 2 , wherein the nanochip is coordinated to operate in conjunction with one or more additional nanochips implanted into a fixed position within the subject.

5. The nanochip of claim 3 , wherein the nanochip is coordinated to operate in conjunction with one or more additional mobile nanochips within the subject.

6. The nanochip of claim 1 , wherein the nanochip is powered by inductive or radiofrequency coupling.

7. The nanochip of claim 1 , wherein the medical condition is kidney disease, liver dysfunction, pancreatitis, thyroid diseases, insulin resistance, paralysis due to severed or dysfunctional neurological pathways, and brain biochemical imbalances.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2012
From: KLINE, ERIC V.
To: INTERNATIONAL BUSINESS MACHINES CORPORATION
Reel/Frame 028438/0348 →
Continuity (1)
Related Publication 20130345525A1 · Dec 26, 2013